Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64,299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
Xu B, Tu S, Song L, Jin Z, Yu B, Fu G, Zhou Y, Wang J, Chen Y, Pu J, Chen L, Qu X, Yang J, Liu X, Guo L, Shen C, Zhang Y, Zhang Q, Pan H, Fu X, Liu J, Zhao Y, Escaned J, Wang Y, Fearon WF, Dou K, Kirtane AJ, Wu Y, Serruys PW, Yang W, Wijns W, Guan C, Leon MB, Qiao S, Stone GW; FAVOR III China study group. Xu B, et al. Among authors: zhang q, zhang y. Lancet. 2021 Dec 11;398(10317):2149-2159. doi: 10.1016/S0140-6736(21)02248-0. Epub 2021 Nov 4. Lancet. 2021. PMID: 34742368 Clinical Trial.
Comparison of long-term in-stent vascular response between abluminal groove-filled biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent: 3-year OCT follow-up from the TARGET I trial.
Xu B, Zhang YJ, Sun ZW, Qiao SB, Chen SL, Zhang RY, Pan DR, Pang S, Zhang Q, Xu L, Yang YJ, Leon MB, Gao RL. Xu B, et al. Among authors: zhang ry, zhang q, zhang yj. Int J Cardiovasc Imaging. 2015 Dec;31(8):1489-96. doi: 10.1007/s10554-015-0721-z. Epub 2015 Jul 26. Int J Cardiovasc Imaging. 2015. PMID: 26208685 Clinical Trial.
Active SB-P Versus Conventional Approach to the Protection of High-Risk Side Branches: The CIT-RESOLVE Trial.
Dou K, Zhang D, Pan H, Guo N, Li L, Li Y, Zhang Q, Liu B, Shen Z, Zhang B, Liu J, Han W, Wang Y, Zhao Y, Yang Y, Chen S, Xie L, Guan C, Kirtane AJ, Xu B; CIT-RESOLVE Investigators. Dou K, et al. Among authors: zhang b, zhang q, zhang d. JACC Cardiovasc Interv. 2020 May 11;13(9):1112-1122. doi: 10.1016/j.jcin.2020.01.233. JACC Cardiovasc Interv. 2020. PMID: 32381188 Free article. Clinical Trial.
Thinner Strut Sirolimus-Eluting BRS Versus EES in Patients With Coronary Artery Disease: FUTURE-II Trial.
Song L, Xu B, Chen Y, Zhou Y, Jia S, Zhong Z, Su X, Ma Y, Zhang Q, Liu J, Wang Y, Guan C, Zheng M, Qiao S, Gao R; FUTURE-II Trial Investigators. Song L, et al. Among authors: zhang q. JACC Cardiovasc Interv. 2021 Jul 12;14(13):1450-1462. doi: 10.1016/j.jcin.2021.04.048. Epub 2021 May 18. JACC Cardiovasc Interv. 2021. PMID: 34238555 Free article. Clinical Trial.
Sirolimus-eluting cobalt alloyed stents in treating patients with coronary artery disease: six-month angiographic and one-year clinical follow-up result. A prospective, historically controlled, multi-center clinical study.
Zhang Q, Xu B, Yang YJ, Zhang RY, Li JP, Qiao SB, Zhang JS, Hu J, Qin XW, Hong T, Chen JL, Huo Y, Shen WF, Gao RL. Zhang Q, et al. Among authors: zhang ry, zhang js. Chin Med J (Engl). 2007 Apr 5;120(7):533-8. Chin Med J (Engl). 2007. PMID: 17442198
Reduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery disease.
Lu L, Wang YN, Li MC, Wang HB, Pu LJ, Niu WQ, Meng H, Yang EL, Zhang RY, Zhang Q, Zhao Q, Chen QJ, De Caterina R, Shen WF. Lu L, et al. Among authors: zhang ry, zhang q. Eur Heart J. 2012 Sep;33(18):2297-306. doi: 10.1093/eurheartj/ehs122. Epub 2012 May 29. Eur Heart J. 2012. PMID: 22645192
64,299 results
You have reached the last available page of results. Please see the User Guide for more information.